Answers are grounded in this paper and cite their sources.
Case report demonstrates SJS/TEN overlap management in a 27-year-old woman, highlighting critical intervention needs.
Introduction Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) overlap is a rare dermatologic emergency caused by a severe hypersensitivity reaction leading to mucocutaneous desquamation. SJS/TEN overlap is diagnosed when the affected total body surface area (TBSA) exceeds 20% but remains below 30%. Management requires an intensive, multidisciplinary approach to prevent life-threatening complications. Here, we present a case of SJS/TEN overlap following treatment of a mood disorder with lamotrigine. Case Description A 27-year-old woman with a history of bipolar disorder presented with diffuse skin eruptions concerning for SJS. She was prescribed lamotrigine as a mood stabilizer three weeks prior. She later developed conjunctival irritation and vaginal discomfort, which were treated with eye drops and corticosteroids. Her condition worsened, developing fever, extensive mucositis, and diffuse sheet-like skin detachment and erosions covering approximately 25-30% of her total body surface area (TBSA), with positive Nikolsky sign (Figure 1). She was tachycardic and febrile but remained hemodynamically stable. Infectious workup was unrevealing. She received multidisciplinary care involving dermatology, ophthalmology, urology, and otolaryngology. Skin biopsy revealed marked dermal-epidermal junction necrolytic alteration consistent with SJS/TEN overlap. Direct immunofluorescence was negative. The patient underwent aggressive fluid and electrolyte resuscitation, multimodal analgesia, and specialized wound care. She also received three courses of intravenous immunoglobulin (IVIG). Due to progressive bullae formation on the trunk and worsening mucosal ulceration, she was transferred to a specialized burn unit for advanced wound management, where she ultimately made a full recovery. Conclusion SJS/TEN overlap represents a dermatologic emergency associated with significant morbidity and a mortality rate approaching 25-49%. The most common triggers are prescription medications, including sulfonamides, allopurinol, nonsteroidal anti-inflammatory drugs, and antiepileptics. Early recognition and prompt intervention are essential to prevent life-threatening complications such as fluid and electrolyte imbalances and sepsis. As demonstrated in this case, the clinical manifestations of SJS/TEN may be nonspecific but can progress rapidly. Therefore, initiation of high-risk medications should be accompanied by close monitoring and surveillance. Effective management requires a multidisciplinary approach. Aggressive intravenous fluid, electrolyte replacement, multimodal analgesia, and specialized wound care remain the cornerstones of therapy for SJS/TEN overlap. The use of intravenous immunoglobulin (IVIG), corticosteroids, and immunomodulatory agents may be considered, although supporting evidence remains limited. Patients with more than 30% TBSA involvement should be transferred to specialized burn units for comprehensive management. Figure 1: Diffuse violaceous macules and papules with blistering and desquamation, with positive Nikolsky sign. [Black box used to de-identify personalized tattoos].
No takes yet. Share an insight, caveat, or question.
Das et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: